Release Date: 01/07/19 08:11 Summary: Final Distribution Announcement Price Sensitive: Yes Download Document 167.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%